OAM
NPTN

Oberweis Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Oberweis Asset Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51,150
Closed -$467K – 178
2015
Q2 		$467K Buy
+51,150
New +$388K 0.12% 98

Other funds holding NPTN

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oberweis Asset Management's NPTN Position: Q3 2015 in Review

Oberweis Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2015, closing a stake of 51,150 shares — an estimated $467K sold.

Oberweis Asset Management first reported a position in NPTN in Q2 2015 and held it in 1 quarter. The position peaked at $467K in Q2 2015. 100 funds tracked by Wall St. Rank hold NPTN as of Q3 2015.

  • Oberweis Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2015 after selling out during the quarter.
  • Oberweis Asset Management sold 51,150 NEOPHOTONICS CORP shares in Q3 2015, an estimated $467K.
  • Oberweis Asset Management first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 1 quarter.
  • Oberweis Asset Management's NEOPHOTONICS CORP position peaked at $467K in Q2 2015.
  • 100 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2015.

Based on Oberweis Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.